tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Evan Seigerman, 108 are a BUY (57.75%), 65 are a HOLD (34.76%), 14 are a SELL (7.49%).
Analyst Evan Seigerman works at BMO with a stock forecast success ratio of 60.95% fulfilled within 133.65 days on average.
Evan Seigerman’s has documented 376 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BIIB, Biogen at 14-Feb-2024.
Analyst best performing recommendations are on STSA (SATSUMA PHARMACEUTICALS).
The best stock recommendation documented was for STSA (SATSUMA PHARMACEUTICALS) at 3/2/2021. The price target of $6.5 was fulfilled within 1 day with a profit of $0.25 (4%) receiving and performance score of 40.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
7 months ago
0/3 (0%)
$95.4 (213.90%)
Buy
160
2 years 4 months 24 days ago
0/1 (0%)
$74.6 (87.35%)
Sell
16.6
$15.47 (1369.03%)
16.8
3 years 5 months 19 days ago
4/4 (100%)
$-12.4 (-42.76%)
335
Buy
120
$118.58 (8350.70%)
4 years 11 months 16 days ago
0/1 (0%)
$56.4 (88.68%)
Buy
200
$198.87 (17599.12%)
140
5 years 5 months 23 days ago
0/2 (0%)
$104 (108.33%)
Which stock is Evan Seigerman is most bullish on?
Which stock is Evan Seigerman is most reserved on?
What Year was the first public recommendation made by Evan Seigerman?
